• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Overuse of Primary Thromboprophylaxis in Medical Inpatients at Low Risk of Venous Thromboembolism.

作者信息

Djulbegovic Mia, Chen Kevin, Sureshanand Soundari, Chaudhry Sarwat

机构信息

National Clinician Scholars Program, Yale University School of Medicine, New Haven, CT, USA.

Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.

出版信息

J Gen Intern Med. 2021 Sep;36(9):2883-2885. doi: 10.1007/s11606-020-05993-x. Epub 2021 Jan 19.

DOI:10.1007/s11606-020-05993-x
PMID:33464465
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8390711/
Abstract
摘要

相似文献

1
Overuse of Primary Thromboprophylaxis in Medical Inpatients at Low Risk of Venous Thromboembolism.低静脉血栓栓塞风险内科住院患者初级血栓预防的过度使用
J Gen Intern Med. 2021 Sep;36(9):2883-2885. doi: 10.1007/s11606-020-05993-x. Epub 2021 Jan 19.
2
Compression stockings in addition to low-molecular-weight heparin to prevent venous thromboembolism in surgical inpatients requiring pharmacoprophylaxis: the GAPS non-inferiority RCT.加压弹力袜联合低分子肝素预防需药物预防的住院手术患者静脉血栓栓塞症：GAPS 非劣效 RCT 研究。
Health Technol Assess. 2020 Dec;24(69):1-80. doi: 10.3310/hta24690.
3
Efficacy of obstetric thromboprophylaxis and long-term risk of recurrence of venous thromboembolism.产科血栓预防的效果和静脉血栓栓塞复发的长期风险。
Acta Obstet Gynecol Scand. 2011 Jun;90(6):648-53. doi: 10.1111/j.1600-0412.2011.01098.x. Epub 2011 Apr 15.
4
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.COVID-19 相关静脉血栓栓塞症：已报告风险和现行指南的系统综述。
Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15.
5
Poor Adherence to Risk Stratification Guidelines Results in Overuse of Venous Thromboembolism Prophylaxis in Hospitalized Older Adults.对风险分层指南的依从性差导致住院老年人静脉血栓栓塞预防措施的过度使用。
J Hosp Med. 2018 Jun 1;13(6):403-404. doi: 10.12788/jhm.2916. Epub 2018 Feb 6.
6
[The PROMET study: Prophylaxis for venous thromboembolic disease in at-risk patients hospitalized in Algeria].
J Mal Vasc. 2015 Jul;40(4):240-7. doi: 10.1016/j.jmv.2015.05.003. Epub 2015 Jun 4.
7
Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.直接口服抗凝剂和低分子肝素用于非心脏手术患者血栓预防的利弊：随机试验的系统评价和网络荟萃分析。
BMJ. 2022 Mar 9;376:e066785. doi: 10.1136/bmj-2021-066785.
8
Venous thromboembolism risk and prophylaxis in hospitalized obstetric patients at a tertiary hospital in Accra, Ghana: A comparative cross-sectional study.加纳阿克拉一家三级医院住院产科患者静脉血栓栓塞风险与预防：一项比较性横断面研究。
Int J Gynaecol Obstet. 2021 Jun;153(3):514-519. doi: 10.1002/ijgo.13504. Epub 2021 Jan 13.
9
Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.抗凝预防血栓失败：内科外科危重症患者的危险因素*。
Crit Care Med. 2015 Feb;43(2):401-10. doi: 10.1097/CCM.0000000000000713.
10
Extended Duration Enoxaparin Decreases the Rate of Venous Thromboembolic Events after Radical Cystectomy Compared to Inpatient Only Subcutaneous Heparin.与仅住院皮下肝素相比，延长依诺肝素持续时间可降低根治性膀胱切除术后静脉血栓栓塞事件的发生率。
J Urol. 2017 Feb;197(2):302-307. doi: 10.1016/j.juro.2016.08.090. Epub 2016 Aug 26.

引用本文的文献

1
Estimated Impact of Model-Guided Venous Thromboembolism Prophylaxis versus Physician Practice.模型指导的静脉血栓栓塞预防与医生常规做法的估计影响
medRxiv. 2025 May 31:2025.05.29.25328593. doi: 10.1101/2025.05.29.25328593.
2
Use of a Risk Assessment Model for Venous Thromboembolism Is Associated with Decreased Prophylaxis.使用静脉血栓栓塞风险评估模型与预防措施减少有关。
J Gen Intern Med. 2025 May 8. doi: 10.1007/s11606-025-09592-6.
3
What Constitutes High Risk for Venous Thromboembolism? Comparing Approaches to Determining an Appropriate Threshold.什么构成静脉血栓栓塞的高风险？比较确定适当阈值的方法。
medRxiv. 2024 Sep 1:2024.08.30.24312871. doi: 10.1101/2024.08.30.24312871.
4
Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis.将 IMPROVE 出血和 VTE 风险评估模型转化为快速而简约的决策树，以优化医院 VTE 预防。
Blood Adv. 2024 Jun 25;8(12):3214-3224. doi: 10.1182/bloodadvances.2024013166.
5
Evaluation of a fast-and-frugal clinical decision algorithm ('pathways') on clinical outcomes in hospitalised patients with COVID-19 treated with anticoagulants.评估一种快速简易的临床决策算法（“路径”）对 COVID-19 住院患者接受抗凝治疗的临床结局的影响。
J Eval Clin Pract. 2023 Feb;29(1):3-12. doi: 10.1111/jep.13780. Epub 2022 Oct 13.

本文引用的文献

1
American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients.美国血液学会 2018 年静脉血栓栓塞症管理指南：住院和非住院医疗患者的预防。
Blood Adv. 2018 Nov 27;2(22):3198-3225. doi: 10.1182/bloodadvances.2018022954.
2
Use of Venous Thromboembolism Prophylaxis in Hospitalized Patients.静脉血栓栓塞症预防在住院患者中的应用。
JAMA Intern Med. 2018 Aug 1;178(8):1122-1124. doi: 10.1001/jamainternmed.2018.2022.
3
The epidemiology of venous thromboembolism.静脉血栓栓塞症的流行病学
J Thromb Thrombolysis. 2016 Jan;41(1):3-14. doi: 10.1007/s11239-015-1311-6.
4
External validation of the risk assessment model of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) for medical patients in a tertiary health system.国际医疗预防静脉血栓栓塞登记处（IMPROVE）风险评估模型在三级医疗系统中对内科患者的外部验证。
J Am Heart Assoc. 2014 Nov 17;3(6):e001152. doi: 10.1161/JAHA.114.001152.
5
External validation of a risk assessment model for venous thromboembolism in the hospitalised acutely-ill medical patient (VTE-VALOURR).急性病住院内科患者静脉血栓栓塞风险评估模型的外部验证（VTE-VALOURR）
Thromb Haemost. 2014 Oct;112(4):692-9. doi: 10.1160/TH14-03-0239. Epub 2014 Jul 3.